Visiongain Publishes Healthcare Distribution Market Report 2021-2031

29 October 2020
Pharma

Visiongain has published a new report on Healthcare Distribution Market Report : Forecasts by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device (Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Healthcare Distribution Market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.

The healthcare distribution market is classified into different sector- Pharmaceuticals product distribution services, medical device distribution services and biopharmaceutical product distribution services.

The largest sector is pharmaceutical product distribution services because in the increase in production of pharmaceutical formulations, outsourcing of pharmaceutical manufacturing and introduction of new manufacturing techniques.

COVID-19 Impact on Healthcare Distribution Market
In this situation of COVID19 this market is only one market which is growing tremendously. Because the threat of this pandemic the world is expecting the better medicines and the most need is covid 19 vaccines. This market is growing in such a way that the players of other sectors are trying to establish in this market.

Market Drivers
The high incidence and large economic crises of chronic disease are primarily driving the market growth, high investments in R&D activities and increasing launch of new rugs and medicines in the healthcare market is supporting the growth of the distribution market.

The technological advancements along with the subsequent growth in track and trace solution in the healthcare distribution industry are further contributing to the growth of the market.

Market Opportunities
The market is gaining pace due to increase in usage of generics in the healthcare sector. Moreover the growing medical device industry is further boosting the demand in the market

The growing biosimilar markets in emerging economics is likely to create potential demands over the period.

Competitive Landscape
The expanding pharmaceutical industry along with the implementation of stringent regulations to enhance the quality and reliability of pharmaceuticals drugs are developing in the emerging economies of the region including all the countries. Some big players in the Healthcare Distribution market are-Mckesson Corporation(US).Amerisource Bergen Corporation(US),Cardinal Health Inc.(US), Owens &Minor, Inc. (US),Morris and Dickson CO. LLC (US), KeySource Medical INC (US),Rochester Drug Cooperative INC(US), Henry Schein Inc.(US),Smith Drug Company (US),FFF Enterprise (US),Patterson Companies Inc (US),Mutual Drug (US)Shanghai Pharmaceuticals Group CO LTD (China),Medline Industries (US),PHOENIX group (Germany), CuraScript SD(US).

Recent Developments
• In April 2019, Cardinal Health partnered with PANTHERx Specialty Pharmacy (US) to fortify its cell and gene therapy product range with a coordinated collection of specialty distribution, third-party logistics (3PL) services, and specialty pharmacy dispensing services.
• In April 2019, McKesson joined hands with Google Cloud (US) to improve new restructured applications and solutions for product manufacturing, specialty pharmaceutical distribution, and retail operations for pharmacies.
• In January 2018, AmerisourceBergen (US) acquired H. D. Smith (US) to augment and expand AmerisourceBergen’s considered scale and strengthen the company’s support to community pharmacies

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever